16 results
424B5
KROS
Keros Therapeutics Inc
4 Jan 24
Prospectus supplement for primary offering
4:02pm
, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing
424B5
KROS
Keros Therapeutics Inc
3 Jan 24
Prospectus supplement for primary offering
4:04pm
securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging
DEF 14A
ciwkptckwumdbqb
19 Apr 21
Definitive proxy
4:15pm
424B4
8m1 n6bd7
13 Nov 20
Prospectus supplement with pricing info
4:02pm
DRS
dm69 5njt7nk
3 Nov 20
Draft registration statement
12:00am
424B4
sw9gbqiyw
8 Apr 20
Prospectus supplement with pricing info
4:58pm
S-1
x515 339e1gr0ve
16 Mar 20
IPO registration
4:57pm
S-1
EX-10.5
i8v0olyo7ulk
16 Mar 20
IPO registration
4:57pm
DRS/A
d7wpeia5i8m8e yl0
27 Feb 20
Draft registration statement (amended)
12:00am
DRS
76j8h0u
21 Jan 20
Draft registration statement
12:00am
- Prev
- 1
- Next